Revolution Medicines, Inc. RVMD
RVMD among the 162 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
RVMD and 9 peers, year by year
The 9 Health care companies closest to RVMD in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | FY2025 | $0 | - | - | - | - | - | −69.3% | - |
| GRAL GRAIL, Inc. | FY2025 | $147.2M | +17.2% | - | −382.0% | −277.5% | −203.8% | −15.8% | - |
| BEAM Beam Therapeutics Inc. | FY2025 | $139.7M | +120% | - | −274.6% | −57.2% | −257.7% | −6.5% | - |
| LGND Ligand Pharmaceuticals Inc | FY2025 | $268.1M | +60.4% | - | 15.3% | 46.4% | 18.2% | 12.2% | - |
| AGIO Agios Pharmaceuticals, Inc. | FY2025 | $54.0M | +48.0% | - | −873.9% | −764.0% | −698.3% | −34.6% | - |
| LMAT Lemaitre Vascular Inc | FY2025 | $249.6M | +13.5% | 71.5% | 27.2% | 23.1% | 29.8% | 14.7% | - |
| RYTM Rhythm Pharmaceuticals, Inc. | FY2025 | $189.8M | +45.8% | - | −101.2% | −103.6% | −61.5% | −141.3% | 0.78 |
| CYTK Cytokinetics Inc | FY2025 | $88.0M | +377% | - | −695.4% | −891.6% | −607.5% | n/m | n/m |
| KYMR Kymera Therapeutics, Inc. | FY2025 | $39.2M | −16.7% | - | −891.1% | −794.0% | −597.6% | −19.7% | - |
| VCEL Vericel Corp | FY2025 | $276.3M | +16.5% | 74.4% | 4.0% | 6.0% | 9.0% | 4.7% | - |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2018 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2018 to FY2025
Revenue as reported in the 10-K.
| Company | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| RVMD Dec | $20.2M | $50.0M | $43.0M | $29.4M | $35.4M | $11.6M | $0 | $0 |
| GRAL Dec | - | - | - | - | $55.5M | $93.1M | $125.6M | $147.2M |
| BEAM Dec | - | $18K | $24K | $51.8M | $60.9M | $377.7M | $63.5M | $139.7M |
| LGND Dec | $251.5M | $120.3M | $163.6M | $241.5M | $196.2M | $131.3M | $167.1M | $268.1M |
| AGIO Dec | $94.4M | $117.9M | $0 | $0 | $14.2M | $26.8M | $36.5M | $54.0M |
| LMAT Dec | $105.6M | $117.2M | $129.4M | $154.4M | $161.7M | $193.5M | $219.9M | $249.6M |
| RYTM Dec | $0 | $0 | $0 | $3.2M | $23.6M | $77.4M | $130.1M | $189.8M |
| CYTK Dec | $31.5M | $26.9M | $55.8M | $70.4M | $94.6M | $7.5M | $18.5M | $88.0M |
| KYMR Dec | - | $2.9M | $34.0M | $72.8M | $46.8M | $78.6M | $47.1M | $39.2M |
| VCEL Dec | $90.9M | $117.8M | $124.2M | $156.2M | $164.4M | $197.5M | $237.2M | $276.3M |
| Peer median | $92.6M | $72.0M | $44.9M | $71.6M | $60.9M | $93.1M | $125.6M | $147.2M |
Sales growth, FY2018 to FY2025
Revenue against the fiscal year before.
| Company | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| RVMD Dec | - | +148% | −14.1% | −31.6% | +20.4% | −67.3% | −100% | - |
| GRAL Dec | - | - | - | - | - | +67.6% | +34.9% | +17.2% |
| BEAM Dec | - | - | +33.3% | n/m | +17.5% | +520% | −83.2% | +120% |
| LGND Dec | +78.2% | −52.2% | +55.0% | +47.7% | −18.8% | −33.1% | +27.3% | +60.4% |
| AGIO Dec | +119% | +24.9% | −100% | - | - | +88.4% | +36.1% | +48.0% |
| LMAT Dec | +4.7% | +11.0% | +10.4% | +19.4% | +4.7% | +19.7% | +13.6% | +13.5% |
| RYTM Dec | - | - | - | - | +649% | +228% | +68.1% | +45.8% |
| CYTK Dec | +136% | −14.7% | +108% | +26.2% | +34.3% | −92.0% | +145% | +377% |
| KYMR Dec | - | - | n/m | +114% | −35.7% | +67.8% | −40.1% | −16.7% |
| VCEL Dec | +44.8% | +29.7% | +3.5% | +25.5% | +6.9% | +20.7% | +20.1% | +16.5% |
| Peer median | +78.2% | +11.0% | +21.8% | +26.2% | +6.9% | +67.6% | +27.3% | +45.8% |
Gross margin, FY2018 to FY2025
Gross profit / revenue.
| Company | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| RVMD Dec | - | - | - | - | - | - | - | - |
| GRAL Dec | - | - | - | - | - | - | - | - |
| BEAM Dec | - | - | - | - | - | - | - | - |
| LGND Dec | - | - | - | - | - | - | - | - |
| AGIO Dec | - | - | - | - | - | - | - | - |
| LMAT Dec | 70.0% | 68.1% | 65.4% | 65.7% | 64.9% | 65.7% | 68.6% | 71.5% |
| RYTM Dec | - | - | - | - | - | - | - | - |
| CYTK Dec | - | - | - | - | - | - | - | - |
| KYMR Dec | - | - | - | - | - | - | - | - |
| VCEL Dec | 64.6% | 68.1% | 67.8% | 67.9% | 66.8% | 68.6% | 72.6% | 74.4% |
| Peer median | - | - | - | - | - | - | - | - |
Operating margin, FY2018 to FY2025
Operating income / revenue.
| Company | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| RVMD Dec | −200.0% | −108.2% | −257.5% | −639.7% | −730.0% | n/m | - | - |
| GRAL Dec | - | - | - | - | n/m | n/m | n/m | −382.0% |
| BEAM Dec | - | n/m | n/m | −757.0% | −555.6% | −46.7% | −654.3% | −274.6% |
| LGND Dec | 65.1% | 671.0% | 22.9% | 43.0% | 1.5% | 9.1% | −13.5% | 15.3% |
| AGIO Dec | −384.0% | −268.2% | - | - | n/m | n/m | n/m | −873.9% |
| LMAT Dec | 26.7% | 18.1% | 22.3% | 23.6% | 16.6% | 19.0% | 23.8% | 27.2% |
| RYTM Dec | - | - | - | n/m | −757.9% | −238.1% | −204.0% | −101.2% |
| CYTK Dec | −282.3% | −368.0% | −168.3% | −264.5% | −342.8% | n/m | n/m | −695.4% |
| KYMR Dec | - | n/m | −136.1% | −138.0% | −344.4% | −210.6% | −555.8% | −891.1% |
| VCEL Dec | −4.3% | −9.5% | 1.9% | −5.0% | −10.4% | −3.3% | 1.9% | 4.0% |
| Peer median | −4.3% | −9.5% | 1.9% | −71.5% | −342.8% | −25.0% | −108.8% | −274.6% |
Net margin, FY2018 to FY2025
Net income / revenue.
| Company | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| RVMD Dec | −207.2% | −95.2% | −251.6% | −636.6% | −703.0% | n/m | - | - |
| GRAL Dec | - | - | - | - | n/m | n/m | n/m | −277.5% |
| BEAM Dec | - | n/m | n/m | −714.9% | −474.5% | −35.1% | −593.1% | −57.2% |
| LGND Dec | 57.0% | 523.2% | −1.8% | 23.7% | −17.0% | 39.7% | −2.4% | 46.4% |
| AGIO Dec | −366.6% | −349.0% | - | - | n/m | n/m | n/m | −764.0% |
| LMAT Dec | 21.7% | 15.3% | 16.4% | 17.4% | 12.8% | 15.6% | 20.0% | 23.1% |
| RYTM Dec | - | - | - | n/m | −766.2% | −238.5% | −200.3% | −103.6% |
| CYTK Dec | −337.4% | −452.9% | −228.0% | −305.7% | −411.2% | n/m | n/m | −891.6% |
| KYMR Dec | - | n/m | −134.0% | −137.6% | −330.6% | −187.0% | −475.6% | −794.0% |
| VCEL Dec | −9.0% | −8.2% | 2.3% | −4.8% | −10.2% | −1.6% | 4.4% | 6.0% |
| Peer median | −9.0% | −8.2% | −1.8% | −71.2% | −330.6% | −18.3% | −101.3% | −103.6% |
Free cash flow, FY2018 to FY2025
Cash from operations minus capital spending.
| Company | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| RVMD Dec | −$286K | −$52.2M | −$103.0M | −$153.7M | −$235.2M | −$358.3M | −$567.7M | −$913.7M |
| GRAL Dec | - | - | - | - | −$584.2M | −$608.7M | −$582.4M | −$299.9M |
| BEAM Dec | - | −$84.5M | −$112.1M | −$113.1M | −$26.4M | −$182.9M | −$356.2M | −$360.0M |
| LGND Dec | $193.2M | −$31.9M | $50.1M | $70.0M | $119.9M | $46.1M | $95.2M | $48.9M |
| AGIO Dec | −$311.4M | −$382.6M | −$304.9M | −$413.1M | −$314.4M | −$297.1M | −$391.5M | −$377.3M |
| LMAT Dec | $16.5M | $10.4M | $31.8M | $30.2M | $22.1M | $29.5M | $37.2M | $74.5M |
| RYTM Dec | −$62.8M | −$126.1M | −$122.2M | −$146.4M | −$173.7M | −$136.2M | −$113.9M | −$116.6M |
| CYTK Dec | −$102.1M | −$93.5M | −$2.1M | −$191.4M | −$310.9M | −$415.7M | −$399.8M | −$534.8M |
| KYMR Dec | - | $17.4M | $79.0M | −$130.5M | −$155.9M | −$137.3M | −$207.3M | −$234.3M |
| VCEL Dec | −$3.1M | −$9.8M | $14.9M | $21.1M | $10.1M | $15.3M | −$5.8M | $24.7M |
| Peer median | −$32.9M | −$58.2M | $6.4M | −$121.8M | −$155.9M | −$137.3M | −$207.3M | −$234.3M |
FCF margin, FY2018 to FY2025
Free cash flow / revenue.
| Company | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| RVMD Dec | −1.4% | −104.3% | −239.6% | −523.0% | −664.8% | n/m | - | - |
| GRAL Dec | - | - | - | - | n/m | −653.8% | −463.7% | −203.8% |
| BEAM Dec | - | n/m | n/m | −218.1% | −43.4% | −48.4% | −560.8% | −257.7% |
| LGND Dec | 76.8% | −26.5% | 30.6% | 29.0% | 61.1% | 35.1% | 57.0% | 18.2% |
| AGIO Dec | −329.9% | −324.5% | - | - | n/m | n/m | n/m | −698.3% |
| LMAT Dec | 15.6% | 8.9% | 24.6% | 19.6% | 13.7% | 15.2% | 16.9% | 29.8% |
| RYTM Dec | - | - | - | n/m | −734.9% | −175.9% | −87.5% | −61.5% |
| CYTK Dec | −324.1% | −348.1% | −3.8% | −271.8% | −328.6% | n/m | n/m | −607.5% |
| KYMR Dec | - | 592.1% | 232.2% | −179.2% | −333.0% | −174.7% | −440.5% | −597.6% |
| VCEL Dec | −3.4% | −8.3% | 12.0% | 13.5% | 6.1% | 7.7% | −2.4% | 9.0% |
| Peer median | −3.4% | −17.4% | 24.6% | −82.9% | −43.4% | −48.4% | −87.5% | −203.8% |
Return on equity, FY2018 to FY2025
Net income / shareholders' equity at the year end.
| Company | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| RVMD Dec | n/m | n/m | −22.8% | −31.0% | −36.3% | −23.9% | −26.5% | −69.3% |
| GRAL Dec | - | - | - | - | - | - | −81.0% | −15.8% |
| BEAM Dec | - | n/m | −79.2% | −44.8% | −39.4% | −13.5% | −51.4% | −6.5% |
| LGND Dec | 25.6% | 82.0% | −0.4% | 7.0% | −5.6% | 7.4% | −0.5% | 12.2% |
| AGIO Dec | −50.3% | −64.2% | −81.9% | 124.2% | −21.1% | −43.4% | 43.7% | −34.6% |
| LMAT Dec | 17.6% | 12.1% | 12.3% | 10.6% | 7.7% | 10.1% | 13.1% | 14.7% |
| RYTM Dec | −30.1% | −50.1% | −80.5% | −24.5% | −68.5% | −108.8% | n/m | −141.3% |
| CYTK Dec | n/m | n/m | −112.3% | −88.3% | n/m | n/m | n/m | n/m |
| KYMR Dec | - | n/m | −16.1% | −21.8% | −31.6% | −37.2% | −26.8% | −19.7% |
| VCEL Dec | −8.0% | −8.7% | 2.1% | −4.4% | −8.7% | −1.4% | 3.5% | 4.7% |
| Peer median | −8.0% | −8.7% | −47.7% | −13.1% | −21.1% | −13.5% | −0.5% | −11.2% |
Debt / equity, FY2018 to FY2025
Total debt / shareholders' equity at the year end.
EPS (diluted), FY2018 to FY2025
Diluted earnings per share, on today's share count after splits.
| Company | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| RVMD Dec | −$21.24 | −$22.33 | −$2.01 | −$2.57 | −$3.08 | −$3.86 | −$3.58 | −$5.95 |
| GRAL Dec | - | - | - | - | −$173.89 | −$47.21 | −$63.54 | −$11.11 |
| BEAM Dec | - | −$14.05 | −$4.19 | −$5.77 | −$4.13 | −$1.72 | −$4.58 | −$0.81 |
| LGND Dec | $5.96 | $31.85 | −$0.18 | $3.31 | −$1.98 | $2.94 | −$0.22 | $6.13 |
| AGIO Dec | −$6.03 | −$6.86 | −$4.74 | $26.55 | −$4.23 | −$6.33 | $11.64 | −$7.12 |
| LMAT Dec | $1.13 | $0.88 | $1.04 | $1.25 | $0.93 | $1.34 | $1.93 | $2.52 |
| RYTM Dec | −$2.39 | −$3.86 | −$3.04 | −$1.40 | −$3.47 | −$3.20 | −$4.34 | −$3.11 |
| CYTK Dec | −$1.95 | −$2.11 | −$1.97 | −$2.80 | −$4.33 | −$5.45 | −$5.26 | −$6.54 |
| KYMR Dec | - | −$24.28 | −$3.15 | −$2.09 | −$2.87 | −$2.52 | −$2.98 | −$3.69 |
| VCEL Dec | −$0.20 | −$0.22 | $0.06 | −$0.16 | −$0.35 | −$0.07 | $0.20 | $0.32 |
| Peer median | −$1.07 | −$2.98 | −$2.50 | −$0.78 | −$3.47 | −$2.52 | −$2.98 | −$3.11 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out RVMD and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: RVMD's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RVMD/export.csv") into a cell.